Idiopathic pulmonary fibrosis
FJ Martinez, HR Collard, A Pardo, G Raghu… - Nature reviews Disease …, 2017 - nature.com
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by
progressive lung scarring and the histological picture of usual interstitial pneumonia (UIP). It …
progressive lung scarring and the histological picture of usual interstitial pneumonia (UIP). It …
The therapy of idiopathic pulmonary fibrosis: what is next?
V Somogyi, N Chaudhuri, SE Torrisi… - European …, 2019 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease, characterised by progressive scarring of the lung and associated with a high …
disease, characterised by progressive scarring of the lung and associated with a high …
An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial …
Background: In 2002 the American Thoracic Society/European Respiratory Society
(ATS/ERS) classification of idiopathic interstitial pneumonias (IIPs) defined seven specific …
(ATS/ERS) classification of idiopathic interstitial pneumonias (IIPs) defined seven specific …
The role of immune and inflammatory cells in idiopathic pulmonary fibrosis
The contribution of the immune system to idiopathic pulmonary fibrosis (IPF) remains poorly
understood. While most sources agree that IPF does not result from a primary …
understood. While most sources agree that IPF does not result from a primary …
Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease
Background IgG 4-related disease (IgG 4-RD) is a systemic condition of unknown cause
characterized by highly fibrotic lesions with dense lymphoplasmacytic infiltrates. CD4+ T …
characterized by highly fibrotic lesions with dense lymphoplasmacytic infiltrates. CD4+ T …
Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis
Systemic sclerosis (SSc) is an autoimmune fibrotic disease whose pathogenesis is poorly
understood and lacks effective therapies. We undertook quantitative analyses of T cell …
understood and lacks effective therapies. We undertook quantitative analyses of T cell …
Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model
A growing body of evidence indicates that aberrant activation of alveolar epithelial cells and
fibroblasts in an aging lung plays a critical role in the pathogenesis of idiopathic pulmonary …
fibroblasts in an aging lung plays a critical role in the pathogenesis of idiopathic pulmonary …
Idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis is a devastating, age-related lung disease of unknown cause
that has few treatment options. This disease was once thought to be a chronic inflammatory …
that has few treatment options. This disease was once thought to be a chronic inflammatory …
Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study
Background The role of the lung microbiome in the pathogenesis of idiopathic pulmonary
fibrosis is unknown. We investigated whether unique microbial signatures were associated …
fibrosis is unknown. We investigated whether unique microbial signatures were associated …
Molecular and cellular mechanisms of pulmonary fibrosis
Pulmonary fibrosis is a chronic lung disease characterized by excessive accumulation of
extracellular matrix (ECM) and remodeling of the lung architecture. Idiopathic pulmonary …
extracellular matrix (ECM) and remodeling of the lung architecture. Idiopathic pulmonary …